SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-13-000005
Filing Date
2013-01-02
Accepted
2013-01-02 13:27:47
Documents
26
Period of Report
2012-12-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tbuff_8k.htm 8-K 27066
2 ARTICLES OF AMALGAMATION tbuff_ex31.htm EX-3.1 14570
3 LETTER TO SHAREHOLDERS tbuff_ex991.htm EX-99.1 19539
4 PRESS RELEASE tbuff_ex992.htm EX-99.2 22270
5 tbuff_ex31001.jpg GRAPHIC 215677
6 tbuff_ex31002.jpg GRAPHIC 63913
7 tbuff_ex31003.jpg GRAPHIC 162509
8 tbuff_ex31004.jpg GRAPHIC 45142
9 tbuff_ex31005.jpg GRAPHIC 39642
10 tbuff_ex31006.jpg GRAPHIC 254951
11 tbuff_ex31007.jpg GRAPHIC 295848
12 tbuff_ex31008.jpg GRAPHIC 306403
13 tbuff_ex31009.jpg GRAPHIC 307269
14 tbuff_ex31010.jpg GRAPHIC 87710
15 tbuff_ex31011.jpg GRAPHIC 71709
16 tbuff_ex31012.jpg GRAPHIC 183297
17 tbuff_ex31013.jpg GRAPHIC 135720
18 tbuff_ex31014.jpg GRAPHIC 133493
19 tbuff_ex31015.jpg GRAPHIC 197954
20 tbuff_ex31016.jpg GRAPHIC 72280
21 tbuff_ex31017.jpg GRAPHIC 195411
22 tbuff_ex31018.jpg GRAPHIC 74041
23 tbuff_ex991001.jpg GRAPHIC 9085
24 tbuff_ex991002.jpg GRAPHIC 4471
25 tbuff_ex992001.jpg GRAPHIC 14554
26 tbuff_ex992002.jpg GRAPHIC 10032
  Complete submission text file 0001354488-13-000005.txt   4057162
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 13501120
SIC: 2834 Pharmaceutical Preparations